Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07093528 · ClinicalTrials.gov registry record

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

A clinical trial of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction, sponsored by Mayo Clinic.

Recruiting
Registry status
25
Enrollment target
1
Study location

NCT07093528: Recruiting study of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction, sponsored by Mayo Clinic.

NCT07093528 is a study of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 25 participants, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07093528, a study of Heart Failure With Preserved Ejection Fraction and Coronary Microvascular Dysfunction, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
25 participants
Enrollment target
1
Study location

Study Summary

To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

Primary Outcome

Endocardial:Epicardial Perfusion Ratio is a measure of myocardial blood flow and will be determined by Cardiovascular magnetic resonance (CMR)

Conditions Studied

Heart Failure With Preserved Ejection Fraction Coronary Microvascular Dysfunction

Interventions

  • DIAGNOSTIC_TEST Cardiovascular Magnetic Resonance (CMR)

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2025-10-16
Est. Completion 2027-08
Mayo Clinic

2,844 total trials

What NCT07093528 shows while recruiting

NCT07093528 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 2,288-participant average among 42 other Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 1 intervention - of which Cardiovascular Magnetic Resonance (CMR) is the first listed.

NCT07093528 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT07093528 about?

NCT07093528 is a clinical study titled "A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD". To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

What is the current status of trial NCT07093528?

This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2025-10-16. Estimated completion is 2027-08.

What conditions does trial NCT07093528 study?

This clinical trial studies the following conditions: Heart Failure With Preserved Ejection Fraction, Coronary Microvascular Dysfunction.

What interventions are being tested in trial NCT07093528?

The interventions under investigation include: Cardiovascular Magnetic Resonance (CMR) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT07093528?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07093528 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07093528's enrollment target sits among peer trials

25 35th of 42 higher than 7 of 42 other Heart Failure With Preserved Ejection Fraction trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure With Preserved Ejection Fraction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT07093528

Source: ClinicalTrials.gov NCT07093528, the US trial registry maintained by the National Library of Medicine. NCT07093528 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.